Table 6.

Frequency and molecular profile of BCL-6 mutations in monoclonal B-cell PTLDs


Case

Histology

Mutation
2916   P-PTLD   449T>C, 645G>C, 823T>A, 978G>A  
3519   P-PTLD   445C>G, 477T>C, 564T>C, 863A>G  
3521   P-PTLD   443A>T, 506A>G, 668A>G, 802A>G, 803C>G, 837T>G  
2909   DLBCL, centroblastic   464T>A, 707T>G, 724T>A, 977A>G, 1102T>G  
3459   DLBCL, centroblastic   855G>A  
3466   DLBCL, centroblastic   479G>A  
3467   DLBCL, centroblastic   453A>C, 459G>C, 506A>C, 692G>C  
3518   DLBCL, centroblastic   523C>T, 1101T>C  
3522   DLBCL, centroblastic   802A>G, 831G>C  
3523   DLBCL, centroblastic   441G>A, 826G>A  
3524   DLBCL, centroblastic   441G>A  
3527   DLBCL, centroblastic   680C>G, 876C>T  
3528   DLBCL, centroblastic   445C>G  
2616   DLBCL, immunoblastic   1031G>C  
2802   DLBCL, immunoblastic   863A>G, 1060T>G  
2892   DLBCL, immunoblastic   479G>C  
2895   DLBCL, immunoblastic   759G>C, 917C>G, 937T>C  
2911   DLBCL, immunoblastic   469A>T, 669T>A  
2915   DLBCL, immunoblastic   480C>G, 837T>G, 975G>A, 1007T>C  
3469   DLBCL, immunoblastic   820G>C, 821G>T  
3476   DLBCL, immunoblastic   567T>G, 570T>C, 608C>T, 624T>G, 626T>A, 889Δ17 bp  
3520   DLBCL, immunoblastic   542A>G, 656G>A, 821G>A, 876C>T, 946C>T, 948T>C, 974G>A, 975G>A, 1052A>C, 1065A>G, 1096T>A  
3529   DLBCL, immunoblastic   1026T>A  
2617   BL/BLL   734G>A, 747A>C, 748G>A  
3463   BL/BLL   476C>G, 496T>C, 519G>C, 537T>A, 635T>C, 702C>G, 724T>C  
3526
 
BL/BLL
 
957A>T
 

Case

Histology

Mutation
2916   P-PTLD   449T>C, 645G>C, 823T>A, 978G>A  
3519   P-PTLD   445C>G, 477T>C, 564T>C, 863A>G  
3521   P-PTLD   443A>T, 506A>G, 668A>G, 802A>G, 803C>G, 837T>G  
2909   DLBCL, centroblastic   464T>A, 707T>G, 724T>A, 977A>G, 1102T>G  
3459   DLBCL, centroblastic   855G>A  
3466   DLBCL, centroblastic   479G>A  
3467   DLBCL, centroblastic   453A>C, 459G>C, 506A>C, 692G>C  
3518   DLBCL, centroblastic   523C>T, 1101T>C  
3522   DLBCL, centroblastic   802A>G, 831G>C  
3523   DLBCL, centroblastic   441G>A, 826G>A  
3524   DLBCL, centroblastic   441G>A  
3527   DLBCL, centroblastic   680C>G, 876C>T  
3528   DLBCL, centroblastic   445C>G  
2616   DLBCL, immunoblastic   1031G>C  
2802   DLBCL, immunoblastic   863A>G, 1060T>G  
2892   DLBCL, immunoblastic   479G>C  
2895   DLBCL, immunoblastic   759G>C, 917C>G, 937T>C  
2911   DLBCL, immunoblastic   469A>T, 669T>A  
2915   DLBCL, immunoblastic   480C>G, 837T>G, 975G>A, 1007T>C  
3469   DLBCL, immunoblastic   820G>C, 821G>T  
3476   DLBCL, immunoblastic   567T>G, 570T>C, 608C>T, 624T>G, 626T>A, 889Δ17 bp  
3520   DLBCL, immunoblastic   542A>G, 656G>A, 821G>A, 876C>T, 946C>T, 948T>C, 974G>A, 975G>A, 1052A>C, 1065A>G, 1096T>A  
3529   DLBCL, immunoblastic   1026T>A  
2617   BL/BLL   734G>A, 747A>C, 748G>A  
3463   BL/BLL   476C>G, 496T>C, 519G>C, 537T>A, 635T>C, 702C>G, 724T>C  
3526
 
BL/BLL
 
957A>T
 

P-PTLD indicates polymorphic PTLD; DLBCL, diffuse large B-cell lymphoma; and BL/BLL, Burkitt lymphoma/Burkitt-like lymphoma.

or Create an Account

Close Modal
Close Modal